Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Although patients with some primary immunodeficiency disorders (PID) exhibit higher rates of vitamin deficiency, there are currently no evidence-based recommendations regarding whether children with PIDs require higher vitamin D supplementation than healthy peers.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D Status in Children with Primary Immunodeficiency Disorders Receiving Vitamin D Supplementation: A Retrospective Cross-Sectional Study
Source: Article title.
Patients were classified according to the 2024 update of the International Union of Immunological Societies (IUIS) phenotypic classification into the following groups:Immunodeficiencies affecting cellular and humoral immunity (n = 5).Combined immunodeficiencies with associated or syndromic features (n = 34).Predominantly antibody deficiencies (n = 40).Diseases of immune dysregulation (n = 22).Congenital defects of phagocyte number or function (n = 13).Defects in intrinsic and innate immunity (n = 4).Autoinflammatory disorders (n = 6).Complement deficiencies (n = 8).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Status in Children with Primary Immunodeficiency Disorders Receiving Vitamin D Supplementation: A Retrospective Cross-Sectional Study
Cross-sectional study · Nutrients · 2026
Original publication title
Vitamin D Status in Children with Primary Immunodeficiency Disorders Receiving Vitamin D Supplementation: A Retrospective Cross-Sectional Study
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Vitamin D plays an important immunomodulatory role, and vitamin D deficiency has been associated with an increased risk of infections and autoimmune disorders. Although patients with some primary immunodeficiency disorders (PID) exhibit higher rates of vitamin deficiency, there are currently no evidence-based recommendations regarding whether children with PIDs require higher vitamin D supplementation than healthy peers. This study aimed to evaluate the nutritional status of vitamin D and vitamin D supplementation in children with PIDs.
Source: BackgroundAbstract: Results
Vitamin D deficiency occurred in 13% of all tested children, and in 22 and 33% of children with predominantly antibody deficiencies and complement deficiencies, respectively, with the median vitamin D supplementation of 1000 IU. The median serum 25(OH)D concentration was 30.75 ng/mL (32.7 ng/mL in girls and 30 ng/mL in boys). The multiple linear regression model showed that the concentration of serum phosphorus level (b = 0.312; p = 0.0497) and immunoglobulin G level (b = 0.433; p = 0.0009) had the greatest influence on the concentration of 25(OH)D. No statistically significant differences in 25(OH)D concentrations were observed among the different IUIS diagnostic groups or between children with normal and low IgG levels.
Source: Results:Abstract: Conclusions
In this retrospective cross-sectional study, children reportedly receiving median 1000 IU supplementation had median 25(OH)D of 30.75 ng/mL with 13% deficiency prevalence; however, causal attribution requires prospective evaluation.
Source: ConclusionsAuthors’ abstract
Background:
Vitamin D plays an important immunomodulatory role, and vitamin D deficiency has been associated with an increased risk of infections and autoimmune disorders. Although patients with some primary immunodeficiency disorders (PID) exhibit higher rates of vitamin deficiency, there are currently no evidence-based recommendations regarding whether children with PIDs require higher vitamin D supplementation than healthy peers. This study aimed to evaluate the nutritional status of vitamin D and vitamin D supplementation in children with PIDs.
Methods:
The study included 132 children diagnosed with PIDs according to the 2024 update of the phenotypic classification by the International Union of Immunological Societies (IUIS). The following variables were evaluated: body mass index (BMI), 25-hydroxyvitamin D (25(OH)D), calcium, phosphorus, immunoglobulins G, A and M, and number of neutrophils and lymphocytes in the blood.
Results:
Vitamin D deficiency occurred in 13% of all tested children, and in 22 and 33% of children with predominantly antibody deficiencies and complement deficiencies, respectively, with the median vitamin D supplementation of 1000 IU. The median serum 25(OH)D concentration was 30.75 ng/mL (32.7 ng/mL in girls and 30 ng/mL in boys). The multiple linear regression model showed that the concentration of serum phosphorus level (b = 0.312; p = 0.0497) and immunoglobulin G level (b = 0.433; p = 0.0009) had the greatest influence on the concentration of 25(OH)D. No statistically significant differences in 25(OH)D concentrations were observed among the different IUIS diagnostic groups or between children with normal and low IgG levels.
Conclusions:
In this retrospective cross-sectional study, children reportedly receiving median 1000 IU supplementation had median 25(OH)D of 30.75 ng/mL with 13% deficiency prevalence; however, causal attribution requires prospective evaluation.
Publication and source details
Original title: Vitamin D Status in Children with Primary Immunodeficiency Disorders Receiving Vitamin D Supplementation: A Retrospective Cross-Sectional Study
Nel Dąbrowska-Leonik; Renata Grzywa-Czuba; Monika Wasiak; Mikołaj Wasil; Weronika Zaczek; Maria Żebrowska; Małgorzata Pac
Nutrients · 2026
* Correspondence: n.dabrowska-leonik@ipczd.pl (N.D.-L.); m.pac@ipczd.pl (M.P.)© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-08T12:11:43+00:00
DOI: 10.3390/nu18172845 · PMC13567533